Cited by 16Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research StudiesHead and Neck Cancer Studies

Topical 5-aminolevulinic acid-mediated photodynamic therapy for basal cell carcinoma

Filonenko, E., Kaprin, A., Urlova, A., Grigorievykh, N., Ivanova-Radkevich, V.·2020·Photodiagnosis and Photodynamic Therapy

Abstract

Topical 5-aminolevulinic acid-mediated photodynamic therapy is an established approach for the treatment of basal cell carcinoma. This study with 5- aminolevulinic acid drug Levulon was conducted in patients with superficial skin basal cell carcinoma. The study included 82 patients with overall number of tumor foci of 119. Tumor sites were as follows: head and neck, trunk, extremities.A total of two photodynamic therapy sessions, four weeks apart were performed using a laser with a wavelength of 630 nm and energy density of 350 J/cm 2. A complete response was recorded in 77 patients (114 foci) with an excellent cosmetic result. According to the analysis of survival in the group of patients with a complete response, the overall RFS was as follows: 1-year rate - 92.1 %, 3-year - 88.3 %. Photodynamic therapy with topical Levulon in patients with superficial BCC of the skin was effective and safe.

Integrity signals

Registry

Crossref · 10.1016/j.pdpdt.2019.101644

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 12 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Filonenko, E., Kaprin, A., Urlova, A., Grigorievykh, N., & Ivanova-Radkevich, V.
Affiliations
Ministry of Health of the Russian Federation (RU)
Venue
Photodiagnosis and Photodynamic Therapy
Publisher
Elsevier BV
Published
2020-06
Volume
30
Pages
101644
ISSN
1572-1000 (ISSN-L)
OpenAlex
W3005988721
Cited by
16
References
12
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 1
FWCI
1.08
Type
journal article
Language
en
Open access
closed
Locations
  • Photodiagnosis and Photodynamic Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Keywords
photodynamic therapy, 5-aminolevulinic acid, basal cell carcinoma, superficial skin cancer, topical treatment, 630 nm laser, recurrence-free survival, cosmetic outcome, treatment safety
MeSH terms
Administration, Topical, Aminolevulinic Acid, Basal Cell Carcinoma, Carcinoma, Basal Cell, Humans, Photochemotherapy, Skin Neoplasms, Photosensitizing Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review